Self-Monitoring Blood Glucose System-United States Market Status and Trend Report 2013-2023
Report Summary
Self-Monitoring Blood Glucose System-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Self-Monitoring Blood Glucose System industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Self-Monitoring Blood Glucose System 2013-2017, and development forecast 2018-2023
Main market players of Self-Monitoring Blood Glucose System in United States, with company and product introduction, position in the Self-Monitoring Blood Glucose System market
Market status and development trend of Self-Monitoring Blood Glucose System by types and applications
Cost and profit status of Self-Monitoring Blood Glucose System, and marketing status
Market growth drivers and challenges
The report segments the United States Self-Monitoring Blood Glucose System market as:
United States Self-Monitoring Blood Glucose System Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Self-Monitoring Blood Glucose System Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose meters
Testing strips
Lancets & Lancing Devices
United States Self-Monitoring Blood Glucose System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes
United States Self-Monitoring Blood Glucose System Market: Players Segment Analysis (Company and Product introduction, Self-Monitoring Blood Glucose System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland), Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan), Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Self-Monitoring Blood Glucose System-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Self-Monitoring Blood Glucose System industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Self-Monitoring Blood Glucose System 2013-2017, and development forecast 2018-2023
Main market players of Self-Monitoring Blood Glucose System in United States, with company and product introduction, position in the Self-Monitoring Blood Glucose System market
Market status and development trend of Self-Monitoring Blood Glucose System by types and applications
Cost and profit status of Self-Monitoring Blood Glucose System, and marketing status
Market growth drivers and challenges
The report segments the United States Self-Monitoring Blood Glucose System market as:
United States Self-Monitoring Blood Glucose System Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Self-Monitoring Blood Glucose System Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose meters
Testing strips
Lancets & Lancing Devices
United States Self-Monitoring Blood Glucose System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes
United States Self-Monitoring Blood Glucose System Market: Players Segment Analysis (Company and Product introduction, Self-Monitoring Blood Glucose System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland), Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan), Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
1.1 Definition of Self-Monitoring Blood Glucose System in This Report
1.2 Commercial Types of Self-Monitoring Blood Glucose System
1.2.1 Blood Glucose meters
1.2.2 Testing strips
1.2.3 Lancets & Lancing Devices
1.3 Downstream Application of Self-Monitoring Blood Glucose System
1.3.1 Type 2 Diabetes
1.3.2 Type 1 Diabetes
1.3.3 Gestational Diabetes
1.4 Development History of Self-Monitoring Blood Glucose System
1.5 Market Status and Trend of Self-Monitoring Blood Glucose System 2013-2023
1.5.1 United States Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
1.5.2 Regional Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Self-Monitoring Blood Glucose System in United States 2013-2017
2.2 Consumption Market of Self-Monitoring Blood Glucose System in United States by Regions
2.2.1 Consumption Volume of Self-Monitoring Blood Glucose System in United States by Regions
2.2.2 Revenue of Self-Monitoring Blood Glucose System in United States by Regions
2.3 Market Analysis of Self-Monitoring Blood Glucose System in United States by Regions
2.3.1 Market Analysis of Self-Monitoring Blood Glucose System in New England 2013-2017
2.3.2 Market Analysis of Self-Monitoring Blood Glucose System in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Self-Monitoring Blood Glucose System in The Midwest 2013-2017
2.3.4 Market Analysis of Self-Monitoring Blood Glucose System in The West 2013-2017
2.3.5 Market Analysis of Self-Monitoring Blood Glucose System in The South 2013-2017
2.3.6 Market Analysis of Self-Monitoring Blood Glucose System in Southwest 2013-2017
2.4 Market Development Forecast of Self-Monitoring Blood Glucose System in United States 2018-2023
2.4.1 Market Development Forecast of Self-Monitoring Blood Glucose System in United States 2018-2023
2.4.2 Market Development Forecast of Self-Monitoring Blood Glucose System by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Self-Monitoring Blood Glucose System in United States by Types
3.1.2 Revenue of Self-Monitoring Blood Glucose System in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Self-Monitoring Blood Glucose System in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Self-Monitoring Blood Glucose System in United States by Downstream Industry
4.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Major Countries
4.2.1 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in New England
4.2.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The Midwest
4.2.4 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The West
4.2.5 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The South
4.2.6 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Southwest
4.3 Market Forecast of Self-Monitoring Blood Glucose System in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
5.1 United States Economy Situation and Trend Overview
5.2 Self-Monitoring Blood Glucose System Downstream Industry Situation and Trend Overview
CHAPTER 6 SELF-MONITORING BLOOD GLUCOSE SYSTEM MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Self-Monitoring Blood Glucose System in United States by Major Players
6.2 Revenue of Self-Monitoring Blood Glucose System in United States by Major Players
6.3 Basic Information of Self-Monitoring Blood Glucose System by Major Players
6.3.1 Headquarters Location and Established Time of Self-Monitoring Blood Glucose System Major Players
6.3.2 Employees and Revenue Level of Self-Monitoring Blood Glucose System Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SELF-MONITORING BLOOD GLUCOSE SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche (Switzerland)
7.1.1 Company profile
7.1.2 Representative Self-Monitoring Blood Glucose System Product
7.1.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
7.2 Abbott (US)
7.2.1 Company profile
7.2.2 Representative Self-Monitoring Blood Glucose System Product
7.2.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Abbott (US)
7.3 LifeScan (US)
7.3.1 Company profile
7.3.2 Representative Self-Monitoring Blood Glucose System Product
7.3.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of LifeScan (US)
7.4 Ascensia (Switzerland)
7.4.1 Company profile
7.4.2 Representative Self-Monitoring Blood Glucose System Product
7.4.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
7.5 Medtronic (Ireland), Dexcom (US)
7.5.1 Company profile
7.5.2 Representative Self-Monitoring Blood Glucose System Product
7.5.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland), Dexcom (US)
7.6 Ypsomed (Switzerland)
7.6.1 Company profile
7.6.2 Representative Self-Monitoring Blood Glucose System Product
7.6.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
7.7 B. Braun (Germany)
7.7.1 Company profile
7.7.2 Representative Self-Monitoring Blood Glucose System Product
7.7.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
7.8 Nipro (Japan), Sanofi (France)
7.8.1 Company profile
7.8.2 Representative Self-Monitoring Blood Glucose System Product
7.8.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nipro (Japan), Sanofi (France)
7.9 ARKRAY (Japan)
7.9.1 Company profile
7.9.2 Representative Self-Monitoring Blood Glucose System Product
7.9.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.10 Prodigy Diabetes Care (US)
7.10.1 Company profile
7.10.2 Representative Self-Monitoring Blood Glucose System Product
7.10.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
7.11 ACON Laboratories (US)
7.11.1 Company profile
7.11.2 Representative Self-Monitoring Blood Glucose System Product
7.11.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
7.12 Nova Biomedical (US)
7.12.1 Company profile
7.12.2 Representative Self-Monitoring Blood Glucose System Product
7.12.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
8.1 Industry Chain of Self-Monitoring Blood Glucose System
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
9.1 Cost Structure Analysis of Self-Monitoring Blood Glucose System
9.2 Raw Materials Cost Analysis of Self-Monitoring Blood Glucose System
9.3 Labor Cost Analysis of Self-Monitoring Blood Glucose System
9.4 Manufacturing Expenses Analysis of Self-Monitoring Blood Glucose System
CHAPTER 10 MARKETING STATUS ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Self-Monitoring Blood Glucose System in This Report
1.2 Commercial Types of Self-Monitoring Blood Glucose System
1.2.1 Blood Glucose meters
1.2.2 Testing strips
1.2.3 Lancets & Lancing Devices
1.3 Downstream Application of Self-Monitoring Blood Glucose System
1.3.1 Type 2 Diabetes
1.3.2 Type 1 Diabetes
1.3.3 Gestational Diabetes
1.4 Development History of Self-Monitoring Blood Glucose System
1.5 Market Status and Trend of Self-Monitoring Blood Glucose System 2013-2023
1.5.1 United States Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
1.5.2 Regional Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Self-Monitoring Blood Glucose System in United States 2013-2017
2.2 Consumption Market of Self-Monitoring Blood Glucose System in United States by Regions
2.2.1 Consumption Volume of Self-Monitoring Blood Glucose System in United States by Regions
2.2.2 Revenue of Self-Monitoring Blood Glucose System in United States by Regions
2.3 Market Analysis of Self-Monitoring Blood Glucose System in United States by Regions
2.3.1 Market Analysis of Self-Monitoring Blood Glucose System in New England 2013-2017
2.3.2 Market Analysis of Self-Monitoring Blood Glucose System in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Self-Monitoring Blood Glucose System in The Midwest 2013-2017
2.3.4 Market Analysis of Self-Monitoring Blood Glucose System in The West 2013-2017
2.3.5 Market Analysis of Self-Monitoring Blood Glucose System in The South 2013-2017
2.3.6 Market Analysis of Self-Monitoring Blood Glucose System in Southwest 2013-2017
2.4 Market Development Forecast of Self-Monitoring Blood Glucose System in United States 2018-2023
2.4.1 Market Development Forecast of Self-Monitoring Blood Glucose System in United States 2018-2023
2.4.2 Market Development Forecast of Self-Monitoring Blood Glucose System by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Self-Monitoring Blood Glucose System in United States by Types
3.1.2 Revenue of Self-Monitoring Blood Glucose System in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Self-Monitoring Blood Glucose System in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Self-Monitoring Blood Glucose System in United States by Downstream Industry
4.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Major Countries
4.2.1 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in New England
4.2.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The Midwest
4.2.4 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The West
4.2.5 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in The South
4.2.6 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Southwest
4.3 Market Forecast of Self-Monitoring Blood Glucose System in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
5.1 United States Economy Situation and Trend Overview
5.2 Self-Monitoring Blood Glucose System Downstream Industry Situation and Trend Overview
CHAPTER 6 SELF-MONITORING BLOOD GLUCOSE SYSTEM MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Self-Monitoring Blood Glucose System in United States by Major Players
6.2 Revenue of Self-Monitoring Blood Glucose System in United States by Major Players
6.3 Basic Information of Self-Monitoring Blood Glucose System by Major Players
6.3.1 Headquarters Location and Established Time of Self-Monitoring Blood Glucose System Major Players
6.3.2 Employees and Revenue Level of Self-Monitoring Blood Glucose System Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SELF-MONITORING BLOOD GLUCOSE SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche (Switzerland)
7.1.1 Company profile
7.1.2 Representative Self-Monitoring Blood Glucose System Product
7.1.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
7.2 Abbott (US)
7.2.1 Company profile
7.2.2 Representative Self-Monitoring Blood Glucose System Product
7.2.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Abbott (US)
7.3 LifeScan (US)
7.3.1 Company profile
7.3.2 Representative Self-Monitoring Blood Glucose System Product
7.3.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of LifeScan (US)
7.4 Ascensia (Switzerland)
7.4.1 Company profile
7.4.2 Representative Self-Monitoring Blood Glucose System Product
7.4.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
7.5 Medtronic (Ireland), Dexcom (US)
7.5.1 Company profile
7.5.2 Representative Self-Monitoring Blood Glucose System Product
7.5.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland), Dexcom (US)
7.6 Ypsomed (Switzerland)
7.6.1 Company profile
7.6.2 Representative Self-Monitoring Blood Glucose System Product
7.6.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
7.7 B. Braun (Germany)
7.7.1 Company profile
7.7.2 Representative Self-Monitoring Blood Glucose System Product
7.7.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
7.8 Nipro (Japan), Sanofi (France)
7.8.1 Company profile
7.8.2 Representative Self-Monitoring Blood Glucose System Product
7.8.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nipro (Japan), Sanofi (France)
7.9 ARKRAY (Japan)
7.9.1 Company profile
7.9.2 Representative Self-Monitoring Blood Glucose System Product
7.9.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.10 Prodigy Diabetes Care (US)
7.10.1 Company profile
7.10.2 Representative Self-Monitoring Blood Glucose System Product
7.10.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
7.11 ACON Laboratories (US)
7.11.1 Company profile
7.11.2 Representative Self-Monitoring Blood Glucose System Product
7.11.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
7.12 Nova Biomedical (US)
7.12.1 Company profile
7.12.2 Representative Self-Monitoring Blood Glucose System Product
7.12.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
8.1 Industry Chain of Self-Monitoring Blood Glucose System
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
9.1 Cost Structure Analysis of Self-Monitoring Blood Glucose System
9.2 Raw Materials Cost Analysis of Self-Monitoring Blood Glucose System
9.3 Labor Cost Analysis of Self-Monitoring Blood Glucose System
9.4 Manufacturing Expenses Analysis of Self-Monitoring Blood Glucose System
CHAPTER 10 MARKETING STATUS ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
